As the race to develop a COVID-19 vaccine for children under 12 continues, patiently-waiting parents who are hungry for answers might try keeping an eye out for a few notable signs of progress, writes The Atlantic.
The first "milestone" will be reached when under-12 vaccine trials stop accepting new participants, notes The Atlantic; after that, researchers "can put all their effort into evaluating the trial itself." As of Wednesday, both Pfizer and Moderna's trials were reportedly still listed as "recruiting" in the National Library of Medicine's clinical-trial database. For context, Pfizer submitted an FDA application for its adolescent vaccine iteration just over two months after closing trial enrollment.
The next and more obvious milestone would be reached when either manufacturer submits an emergency use authorization application. Then, in the case of Pfizer, the company's 12-to-15-year-old EUA was approved a month after its submission.
Subscribe to The Week
Escape your echo chamber. Get the facts behind the news, plus analysis from multiple perspectives.
Sign up for The Week's Free Newsletters
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
However, late last month, Pfizer and Moderna both extended the recruitment phrases for their under-12 vaccine clinical trials. The FDA, which requested the extension, said it is concerned about "having a large-enough sample size to detect rare side effects," writes The Atlantic. It is unclear how much time the extra recruiting will take.
So, in the meantime, the best way to protect young children continues to be "masking, quality ventilation, frequent testing, and vaccinating as many adults and adolescents as possible," writes The Atlantic.
-
August 10 editorial cartoonsCartoons Sunday's political cartoons include a global plastics problem, GOP enthusiasm over tariffs, and more
-
5 thin-skinned cartoons about shooting the messengerCartoons Artists take on unfavorable weather, a look in the mirror, and more
-
Is Trump's new peacemaking model working in DR Congo?Talking Point Truce brokered by the US president in June is holding, but foundations of a long-term peace have let to be laid
-
Lithium shows promise in Alzheimer's studySpeed Read Potential new treatments could use small amounts of the common metal
-
Scientists discover cause of massive sea star die-offSpeed Read A bacteria related to cholera has been found responsible for the deaths of more than 5 billion sea stars
-
'Thriving' ecosystem found 30,000 feet underseaSpeed Read Researchers discovered communities of creatures living in frigid, pitch-black waters under high pressure
-
New York plans first nuclear plant in 36 yearsSpeed Read The plant, to be constructed somewhere in upstate New York, will produce enough energy to power a million homes
-
Dehorning rhinos sharply cuts poaching, study findsSpeed Read The painless procedure may be an effective way to reduce the widespread poaching of rhinoceroses
-
Breakthrough gene-editing treatment saves babyspeed read KJ Muldoon was healed from a rare genetic condition
-
Sea lion proves animals can keep a beatspeed read A sea lion named Ronan beat a group of college students in a rhythmic dance-off, says new study
-
Humans heal much slower than other mammalsSpeed Read Slower healing may have been an evolutionary trade-off when we shed fur for sweat glands
